Clinical Trial Update: A Study of SHR3680 in Treating Patients With Hormone Sensitive Prostate Cancer [Phase 3]

View source ↗

Summary

Phase 3 study update for SHR3680 in hormone-sensitive prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-dependent Prostate Cancer
• Prostate Cancer

Drugs mentioned

• SHR3680

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Prostate Cancer, Hormone-Dependent Prostate Cancer | Phase 3 | Status: UNKNOWN